Carthamus tinctorius Linn.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Family | Asteraceae. |
| Habitat | Cultivated mainly as an oil-seed crop in Madhya Pradesh, Maharashtra. |
| English | Safflower. |
| Ayurvedic | Kusumbha, Vahinshikhaa, Vastraranjaka, Kusum. |
| Unani | Qurtum. |
| Siddha / Tamil | Chendurakam. |
| Action | Oil—aids prevention of arteriosclerosis, coronary heart disease and kidney disorders as a polyunsaturated fat. Flowers— stimulant, sedative, diuretic, emmenagogue; used in fevers and eruptive skin conditions, measles. Charred safflower oil is used in rheumatism and for healing sores. |
| Key Application | Dried flowers— in cardiovascular diseases, amenorrhoea, dysmenorrhoea and retention of lochia; also in wounds and sores with pain and swelling. (Pharmocopoeia of the People’s Republic of China, 1997.) |
| Dosage | Leaf—3–6 g powder. (CCRAS.) |
| Taxonomic Cohort | Genus Carthamus (1 documented species); Family Asteraceae (12 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Carthamus tinctorius (taxonomically cited with authority Linn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Asteraceae (primary family classification: Asteraceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Cultivated mainly as an oil-seed crop in Madhya Pradesh, Maharashtra.
Across classical and vernacular Indian systems of medicine, Carthamus tinctorius is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Safflower; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Kusumbha, Vahinshikhaa, Vastraranjaka, Kusum; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Qurtum; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Chendurakam. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Carthamus tinctorius are: Oil—aids prevention of arteriosclerosis, coronary heart disease and kidney disorders as a polyunsaturated fat. Flowers— stimulant, sedative, diuretic, emmenagogue; used in fevers and eruptive skin conditions, measles. Charred safflower oil is used in rheumatism and for healing sores. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias. Furthermore, international and national regulatory monographs highlight its validated key clinical application: Dried flowers— in cardiovascular diseases, amenorrhoea, dysmenorrhoea and retention of lochia; also in wounds and sores with pain and swelling. (Pharmocopoeia of the People’s Republic of China, 1997.).
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Carthamus tinctorius establish the following evidence base: Safflower contains carthamone, lignans and a polysaccharide. The polysaccharide, composed of xylose, fructose, galactose, glucose, arabinose, rhamnose and uronic acid residues, stimulates immune function in mice. It induced antibody formation in mice following peritoneal injection. Extracts of flowers have also been tested in China on blood coagulation, where a prolongation of clothing time was observed and platelet aggregation inhibited. Chinese research indicates that Safflower flowers can reduce coronary artery disease, and lower cholesterol levels. Flowers and seeds exhibit lipase activity. The flower extract also exhibited anti-inflammatory, sedative and analgesic effect and inhibitory effect on spontaneous motor activity. The plant contains a propanetriol derivative, which can be used for the treatment of circulatory disorders. Recent research suggests that improving the lipid profile might not be as important to reducing the risk of cardiovascular disease as suggested. (Natural Medicines Comprehensive Database, 2007.) Safflower is contraindicated in pregnancy, gastric disorders, excessive menstruation, haemorrhagic diseases. Wild and thorny Safflower, growing in the arid tract of Haryana and Punjab (locally known as Kantiaari, Poli, Poiyan) is equated with C. oxycantha Bieb. The plant is diuretic. Seed oil is applied topically to ulcers. The plant contains a sesquiterpene glycoside. Aerial parts contain hinesolbeta-D-fucopyranoside. The plant also contains luteolin-7-glucoside.
In specialized pharmacognostic classifications, Carthamus tinctorius is also represented by authenticated macro-photographic crude drug specimens in institutional pharmacognostic collections.

Figure 1: Authenticated crude herb specimen — Carthamus tinctorius seed.

Botanical Reference 1: Safflower — Botanical specimen

Botanical Reference 2: Safflower — Botanical specimen

Botanical Reference 3: Carthamus tinctorius — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Within Indian medicinal flora, Carthamus tinctorius stands as a distinct representative of the genus Carthamus. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.
At the family level, Asteraceae encompasses 12 documented medicinal species (0.66% of the 1,814-species flora). Other representative medicinal members of Asteraceae include: Ageratum conyzoides (Dochunty), Anthemis nobilis (Roman Chamomile), Centratherum anthelminticum (Aranya-Jiraka), Gnaphalium luteo-album (Jersey Cudweed), Gynura pseudo-china. In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 2: Quantitative documentation profile across all 12 medicinal species of family Asteraceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
For clinical and traditional dispensing, the standardized posology and crude herb dosage for Carthamus tinctorius are prescribed as follows: Leaf—3–6 g powder. (CCRAS.). Crude drug dosages are calibrated against The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and the Standard Nomenclature of Ayurvedic Medicinal Plants published by the Central Council for Research in Ayurveda and Siddha (CCRAS). Classical and modern pharmacognostic synchronization for Carthamus tinctorius integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.